Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Schmidt

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
JCI Insight|July 21, 2017
TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potencyMathilde Allard, Barbara Couturaud, Laura Carretero-Iglesia, et al.
Genome Biology|February 28, 2008
UTILLdb, a Pisum sativum in silico forward and reverse genetics toolMarion Dalmais, Julien Schmidt, Christine Le Signor, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 9, 2009
Breast cancer resistance protein (BCRP/ABCG2): new inhibitors and QSAR studies by a 3D linear solvation energy approachEdwige Nicolle, Julien Boccard, David Guilet, et al.
Iscience|March 23, 2023
Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinityHajer Fritah, Michele Graciotti, Cheryl Lai-Lai Chiang, et al.
Science Translational Medicine|January 28, 2026
Skin thermal dynamics and hypothalamic thermosensitivity dissociate REM sleep and cataplexy in narcolepsyBianca Viberti, Simone Bellini, Amarine Chancel, et al.
Immunity|April 6, 2023
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopesJulien Racle, Philippe Guillaume, Julien Schmidt, et al.
Cell Reports Methods|May 9, 2023
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRsRaphael Genolet, Sara Bobisse, Johanna Chiffelle, et al.
Cell Reports. Medicine|March 5, 2021
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoeditingJulien Schmidt, Angela R Smith, Morgane Magnin, et al.
BMJ Open|April 17, 2024
Restrictive use of Restraints and Delirium Duration in the Intensive Care Unit (R2D2-ICU): protocol for a French multicentre parallel-group open-label randomised controlled trialRomain Sonneville, Camille Couffignal, Florian Sigaud, et al.
Science Advances|June 11, 2025
Phage display enables machine learning discovery of cancer antigen-specific TCRsGiancarlo Croce, Rachid Lani, Delphine Tardivon, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
JCI Insight|July 21, 2017
TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potencyMathilde Allard, Barbara Couturaud, Laura Carretero-Iglesia, et al.
Genome Biology|February 28, 2008
UTILLdb, a Pisum sativum in silico forward and reverse genetics toolMarion Dalmais, Julien Schmidt, Christine Le Signor, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 9, 2009
Breast cancer resistance protein (BCRP/ABCG2): new inhibitors and QSAR studies by a 3D linear solvation energy approachEdwige Nicolle, Julien Boccard, David Guilet, et al.
Iscience|March 23, 2023
Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinityHajer Fritah, Michele Graciotti, Cheryl Lai-Lai Chiang, et al.
Science Translational Medicine|January 28, 2026
Skin thermal dynamics and hypothalamic thermosensitivity dissociate REM sleep and cataplexy in narcolepsyBianca Viberti, Simone Bellini, Amarine Chancel, et al.
Immunity|April 6, 2023
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopesJulien Racle, Philippe Guillaume, Julien Schmidt, et al.
Cell Reports Methods|May 9, 2023
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRsRaphael Genolet, Sara Bobisse, Johanna Chiffelle, et al.
Cell Reports. Medicine|March 5, 2021
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoeditingJulien Schmidt, Angela R Smith, Morgane Magnin, et al.
BMJ Open|April 17, 2024
Restrictive use of Restraints and Delirium Duration in the Intensive Care Unit (R2D2-ICU): protocol for a French multicentre parallel-group open-label randomised controlled trialRomain Sonneville, Camille Couffignal, Florian Sigaud, et al.
Science Advances|June 11, 2025
Phage display enables machine learning discovery of cancer antigen-specific TCRsGiancarlo Croce, Rachid Lani, Delphine Tardivon, et al.
Pageof 6